Boehringer Ingelheim, one of the world’s leading pharmaceutical companies has unveiled a global training and awareness programme on albinism in an effort to safeguard persons with albinism from discrimination and raise awareness in their environment. The programme will educate people with albinism, their families, friends and health care providers on the importance of protecting those affected by the condition. It will be implemented in close collaboration with key partners - Ampath, Golden Age Albinism Support Group (GAASP) and Positive Exposure, all based in Kenya. The training which will be rolled out in Western Kenya will also focus on health and safety conditions for people living with albinism in the region while emphasizing on the importance of the community to embrace and protect those with the condition in their environment. Jane Waithera, the founder of Positive Exposure says a comprehensive programme has been designed in collaboration with Boehringer Ingelheim and the ...
